Exogenous HGH

HGH treatment is intended to regenerate the thymus gland. Long-term growth hormone replacement therapy has been shown to improve bone mineral density in adults with GHD. GHRT has been shown to reduce cardiovascular disease risk factors in adults with GHD. GHRT prescribing data could not be fully captured in this study because the therapy is predominantly prescribed in secondary care, preventing investigation of treatment effects on outcomes. HGH therapy response is assessed through IGF-1 monitoring. Future research priorities include evaluating the impact of hormone replacement therapies on long-term morbidity and quality of life in population-based settings. Even with GHRT, adults with GHD report worse quality of life than unaffected controls, suggesting GHRT does not fully normalise outcomes. As many as 11% of high school students have reported trying HGH, despite significant long-term reproductive risks. Exogenous HGH triggers negative feedback, causing the pituitary gland to reduce its own natural HGH production. Exogenous HGH causes testicular atrophy in males, directly impairing fertility. After growth plates close, exogenous HGH causes continued growth in peripheral bones —…